Business Wire2d
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Neuroscience News3d
Unlocking Cellular Youth: The Protein That Reverses Aging
AP2A1 could serve as a biomarker for aging and a target for therapies aimed at slowing down or even reversing the aging ...